TR201106844T2 - Moksi̇floksasi̇n yaş granülasyonunda organi̇k solventleri̇n kullanimi. - Google Patents
Moksi̇floksasi̇n yaş granülasyonunda organi̇k solventleri̇n kullanimi.Info
- Publication number
- TR201106844T2 TR201106844T2 TR2011/06844T TR201106844T TR201106844T2 TR 201106844 T2 TR201106844 T2 TR 201106844T2 TR 2011/06844 T TR2011/06844 T TR 2011/06844T TR 201106844 T TR201106844 T TR 201106844T TR 201106844 T2 TR201106844 T2 TR 201106844T2
- Authority
- TR
- Turkey
- Prior art keywords
- moxifloxacin
- granulation
- age
- organic solvents
- organic solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Buluş, organik çözücü veya organik çözücü karışımları ile yaş granülasyon metodu kullanarak, dönüştürülemez anhidms moksifloksasin katı farmasötik formülasyonu elde etmeyi kapsar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2008/054141 WO2010041100A1 (en) | 2008-10-09 | 2008-10-09 | Using of organic solvents in wet granulation of moxifloxacin |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201106844T2 true TR201106844T2 (tr) | 2012-02-21 |
Family
ID=40070762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2011/06844T TR201106844T2 (tr) | 2008-10-09 | 2008-10-09 | Moksi̇floksasi̇n yaş granülasyonunda organi̇k solventleri̇n kullanimi. |
Country Status (12)
Country | Link |
---|---|
US (1) | US8314122B2 (tr) |
EP (1) | EP2349220B1 (tr) |
JP (1) | JP5461565B2 (tr) |
CN (1) | CN102176902B (tr) |
BR (1) | BRPI0823092A2 (tr) |
EA (1) | EA201170545A1 (tr) |
ES (1) | ES2391132T3 (tr) |
MX (1) | MX2011003731A (tr) |
PL (1) | PL2349220T3 (tr) |
PT (1) | PT2349220E (tr) |
TR (1) | TR201106844T2 (tr) |
WO (1) | WO2010041100A1 (tr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200907227A2 (tr) * | 2009-09-18 | 2011-04-21 | Bi̇lgi̇ç Mahmut | Çözünürlüğü yüksek stabil mikronize granüller. |
EP2491921A1 (en) * | 2011-02-25 | 2012-08-29 | Deva Holding Anonim Sirketi | Conservation of anhydrous form of gemifloxacin |
CN102204911B (zh) * | 2011-03-25 | 2013-04-17 | 华润赛科药业有限责任公司 | 一种盐酸莫西沙星药物组合物及其制备方法 |
BRPI1106900A2 (pt) * | 2011-12-26 | 2013-11-05 | Ems Sa | Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção |
FR2992218B1 (fr) | 2012-06-22 | 2015-01-23 | Rivopharm Sa | Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation |
SI3265084T1 (sl) * | 2015-03-03 | 2024-04-30 | Pharmacyclics Llc | Farmacevtske formulacije inhibitorja Burtonove tirozin kinaze |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3906365A1 (de) | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
EP0782449B1 (en) * | 1994-09-22 | 2003-04-09 | Akzo Nobel N.V. | Process of making dosage units by wet granulation |
DE19546249A1 (de) * | 1995-12-12 | 1997-06-19 | Bayer Ag | Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen |
DK1128831T3 (da) * | 1998-11-10 | 2005-01-17 | Bayer Healthcare Ag | Farmaceutisk moxifloxacinpræparat |
EP1562942A1 (en) * | 2002-10-31 | 2005-08-17 | Ranbaxy Laboratories, Ltd. | Amorphous moxifloxacin hydrochloride |
GB0301259D0 (en) * | 2003-01-20 | 2003-02-19 | Novartis Ag | Organic compounds |
US7230006B2 (en) * | 2003-04-09 | 2007-06-12 | Reddy's Laboratories Limited | Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof |
US20050031683A1 (en) * | 2003-08-04 | 2005-02-10 | Ashish Kapoor | Solid pharmaceutical composition |
DE102005036195A1 (de) | 2005-08-02 | 2007-02-08 | Robert Bosch Gmbh | Handwerkzeugmaschine |
GB0612422D0 (en) * | 2006-06-23 | 2006-08-02 | Generics Uk Ltd | Novel hydrate form |
-
2008
- 2008-10-09 CN CN200880131455XA patent/CN102176902B/zh not_active Expired - Fee Related
- 2008-10-09 ES ES08807939T patent/ES2391132T3/es active Active
- 2008-10-09 PT PT08807939T patent/PT2349220E/pt unknown
- 2008-10-09 WO PCT/IB2008/054141 patent/WO2010041100A1/en active Application Filing
- 2008-10-09 TR TR2011/06844T patent/TR201106844T2/tr unknown
- 2008-10-09 MX MX2011003731A patent/MX2011003731A/es not_active Application Discontinuation
- 2008-10-09 BR BRPI0823092A patent/BRPI0823092A2/pt not_active IP Right Cessation
- 2008-10-09 JP JP2011530582A patent/JP5461565B2/ja not_active Expired - Fee Related
- 2008-10-09 PL PL08807939T patent/PL2349220T3/pl unknown
- 2008-10-09 US US13/122,935 patent/US8314122B2/en not_active Expired - Fee Related
- 2008-10-09 EA EA201170545A patent/EA201170545A1/ru unknown
- 2008-10-09 EP EP08807939A patent/EP2349220B1/en not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
CN102176902B (zh) | 2012-10-31 |
US20110198774A1 (en) | 2011-08-18 |
EA201170545A1 (ru) | 2012-01-30 |
ES2391132T3 (es) | 2012-11-21 |
BRPI0823092A2 (pt) | 2015-09-29 |
EP2349220A1 (en) | 2011-08-03 |
PT2349220E (pt) | 2012-10-11 |
JP2012505194A (ja) | 2012-03-01 |
PL2349220T3 (pl) | 2012-12-31 |
EP2349220B1 (en) | 2012-07-25 |
JP5461565B2 (ja) | 2014-04-02 |
WO2010041100A1 (en) | 2010-04-15 |
US8314122B2 (en) | 2012-11-20 |
MX2011003731A (es) | 2011-08-03 |
CN102176902A (zh) | 2011-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11861A (es) | Compuestos organicos | |
CY1117615T1 (el) | Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης | |
CY1117934T1 (el) | Αντιβακτηριακες φαρμακευτικες συνθεσεις | |
CL2011000846A1 (es) | Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
CL2015000829A1 (es) | Inhibidores de histona desmetilasas | |
DOP2011000172A (es) | Compuestos organicos | |
ECSP11011184A (es) | Compuestos orgánicos | |
CL2012002189A1 (es) | Compuestos derivados de pirrolidina-2-carboxamidas sustituidas; inhibidores de la interaccion mdm2-p53; composicion farmaceutica; y su uso para el tratamiento del cancer, en particular de tumores solidos. | |
ECSP11011181A (es) | Compuestos orgánicos | |
CL2012003415A1 (es) | Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer . | |
CL2008000156A1 (es) | Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel. | |
CL2013000104A1 (es) | Compuestos derivados de heterociclicos nitrogenados sustituidos, agonistas del receptor ip; composicion farmaceutica; combinación farmaceutica; y uso para el tratamiento de la hipertension arterial pulmonar. | |
EA201492011A1 (ru) | Безводные фармацевтические составы для местного применения | |
CL2011001333A1 (es) | Compuestos derivados de heterociclos nitrogenados sustituidos, inhibidores de ns5a; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c. | |
DOP2011000175A (es) | Compuestos organicos | |
CL2013002053A1 (es) | Compuestos derivados de heterociclicos, antagonistas del receptor de glucagon; composicion farmaceutica que lo comprende y su uso en el tratamiento de diabetes y enfermedades metabolicas. pct | |
CL2012003564A1 (es) | Compuestos derivados de heteroaril limidazolona :composición farmacéutica;uso de los compuestos para la inhibición de jak1,jak2 y jak3; y combinaciones farmacéuticas. | |
BRPI0908097A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica. | |
IN2015DN01315A (tr) | ||
TR201106844T2 (tr) | Moksi̇floksasi̇n yaş granülasyonunda organi̇k solventleri̇n kullanimi. | |
CY1116111T1 (el) | Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης | |
CL2008001123A1 (es) | Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer. | |
BR112014020104A8 (pt) | Polímeros conjugados | |
BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. | |
BRPI0921654A2 (pt) | formulação farmacêutica |